Literature DB >> 6265375

Psoralen inactivation of influenza and herpes simplex viruses and of virus-infected cells.

D C Redfield, D D Richman, M N Oxman, L H Kronenberg.   

Abstract

Psoralen compounds covalently bind to nucleic acids when irradiated with long-wavelength ultraviolet light. This treatment can destroy the infectivity of deoxyribonucleic acid and ribonucleic acid viruses. Two psoralen compounds, 4'-hydroxymethyltrioxsalen and 4'-aminomethyltrioxsalen, were used with long-wavelength ultraviolet light to inactivate cell-free herpes simplex and influenza viruses and to render virus-infected cells noninfectious. This method of inactivation was compared with germicidal (short-wavelength) ultraviolet light irradiation. The antigenicity of the treated, virus-infected, antigen-bearing cells was examined by immunofluorescence and radioimmunoassay and by measuring the capacity of the herpes simplex virus-infected cells to stimulate virus-specific lymphocyte proliferation. The infectivity of the virus-infected cells could be totally eliminated without altering their viral antigenicity. The use of psoralen plus long-wavelength ultraviolet light is well suited to the preparation of noninfectious virus antigens and virus antigen-bearing cells for immunological assays.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6265375      PMCID: PMC351582          DOI: 10.1128/iai.32.3.1216-1226.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Molecular and genetic basis of furocoumarin reactions.

Authors:  B R Scott; M A Pathak; G R Mohn
Journal:  Mutat Res       Date:  1976       Impact factor: 2.433

2.  SEPARATION OF VIABLE LYMPHOCYTES FROM HUMAN BLOOD.

Authors:  A S COULSON; D G CHALMERS
Journal:  Lancet       Date:  1964-02-29       Impact factor: 79.321

3.  PHOTOSENSITIZING FUROCOUMARINS: INTERACTION WITH DNA AND PHOTO-INACTIVATION OF DNA CONTAINING VIRUSES.

Authors:  L MUSAJO; G RODIGHIERO; G COLOMBO; V TORLONE; F DALLACQUA
Journal:  Experientia       Date:  1965-01-15

4.  ANTIRABIC IMMUNIZATION WITH CULTURE VIRUS RENDERED AVIRULENT BY ULTRA-VIOLET LIGHT.

Authors:  H L Hodes; G I Lavin; L T Webster
Journal:  Science       Date:  1937-11-12       Impact factor: 47.728

Review 5.  Killing of virus-infected cells by cytotoxic lymphocytes.

Authors:  J G Sissons; M B Oldstone
Journal:  J Infect Dis       Date:  1980-07       Impact factor: 5.226

Review 6.  Photochemistry and photobiology of psoralens.

Authors:  P S Song; K J Tapley
Journal:  Photochem Photobiol       Date:  1979-06       Impact factor: 3.421

7.  Genetic recombination induced by DNA cross-links in repressed phage lambda.

Authors:  P Howard-Flanders; P F Lin
Journal:  Genetics       Date:  1973-04       Impact factor: 4.562

8.  Photochemical cross-linking of DNA-RNA helices by psoralen derivatives.

Authors:  C K Shen; T S Hsieh; J C Wang; J E Hearst
Journal:  J Mol Biol       Date:  1977-11       Impact factor: 5.469

9.  Inactivation of influenza and vesicular stomatitis virion RNA polymerase activities by photoreaction with 4'-substituted psoralens.

Authors:  K Nakashima; P K Chanda; V Deutsch; A K Banerjee; A J Shatkin
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

10.  Synthesis and characterization of new psoralen derivatives with superior photoreactivity with DNA and RNA.

Authors:  S T Isaacs; C K Shen; J E Hearst; H Rapoport
Journal:  Biochemistry       Date:  1977-03-22       Impact factor: 3.162

View more
  17 in total

1.  Rapid dot-immunobinding assay on nitrocellulose for viral antibodies.

Authors:  R L Heberling; S S Kalter
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

2.  Evaluation and reporting of enzyme immunoassay determinations of antibody to herpes simplex virus in sera and cerebrospinal fluid.

Authors:  N E Cremer; C K Cossen; C V Hanson; G R Shell
Journal:  J Clin Microbiol       Date:  1982-05       Impact factor: 5.948

3.  Insect virus: assays for toxic effects and transformation potential in mammalian cells.

Authors:  P C Hartig; M A Chapman; G G Hatch; C Y Kawanishi
Journal:  Appl Environ Microbiol       Date:  1989-08       Impact factor: 4.792

4.  Influenza virus-membrane fusion triggered by proton uncaging for single particle studies of fusion kinetics.

Authors:  Deirdre A Costello; Donald W Lee; Jennifer Drewes; Kevin A Vasquez; Kassandra Kisler; Ulrich Wiesner; Lois Pollack; Gary R Whittaker; Susan Daniel
Journal:  Anal Chem       Date:  2012-10-01       Impact factor: 6.986

5.  Ganciclovir prophylaxis for cochlear pathophysiology during experimental guinea pig cytomegalovirus labyrinthitis.

Authors:  N K Woolf; J W Ochi; E J Silva; P A Sharp; J P Harris; D D Richman
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

6.  Prevalence of antibodies to four human coronaviruses is lower in nasal secretions than in serum.

Authors:  Geoffrey J Gorse; Gira B Patel; Joseph N Vitale; Theresa Z O'Connor
Journal:  Clin Vaccine Immunol       Date:  2010-10-13

7.  Inactivated bovine herpesvirus 1 induces apoptotic cell death of mitogen-stimulated bovine peripheral blood mononuclear cells.

Authors:  E Hanon; A Vanderplasschen; S Lyaku; G Keil; M Denis; P P Pastoret
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

8.  Enzyme immunofiltration technique for rapid diagnosis of herpes simplex virus eye infections in a rabbit model.

Authors:  P H Cleveland; D D Richman; D C Redfield; D R Disharoon; P S Binder; M N Oxman
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

9.  Identification and analysis of an alcelaphine herpesvirus 1 (AHV-1) cDNA clone expressing a fusion protein recognized by AHV-1-neutralizing antisera.

Authors:  R S Lahijani; S M Sutton; R B Klieforth; W P Heuschele
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

10.  Hydrophobic inactivation of influenza viruses confers preservation of viral structure with enhanced immunogenicity.

Authors:  Yossef Raviv; Robert Blumenthal; S Mark Tompkins; Jennifer Humberd; Robert J Hogan; Mathias Viard
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.